Position in SVTR
Snapshot 2026-10-28- Startup SignalsTop 50%new
- Life SciencesTop 50%
- Healthcare ServicesRankedof 86
- Search#4of 12
About
Vera Health (YC-backed), founded in 2024 in San Francisco, is an AI clinical evidence search engine that synthesizes 60M+ peer-reviewed papers, guidelines and drug references into cited, evidence-graded answers for clinicians.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2026-10-27Series A$29M
Investors · Threshold Ventures, Mantis VC, SV Angel, Y Combinator, Gradient VenturesSource · verahealth.ai ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Vera Health
Vera Health (YC-backed), founded in 2024 in San Francisco, is an AI clinical evidence search engine that synthesizes 60M+ peer-reviewed papers, guidelines and drug references into cited, evidence-graded answers for clinicians.
Series A · $32M · 2026-10
$32M
United States
BusinessLatest roundTotal raisedDate- OpenEvidence
AI medical evidence search and clinical decision support platform for clinicians
Undisclosed · $1.1B · 2026-09 · Valuation $15B
$1.1BValuation $15B - Health Data Analytics Institute
Uses predictive analytics and machine learning to help clinicians make better patient care decisions
Series C · $31M · 2023-10
$31M - Freed
AI assistant that helps clinicians document patient visits
Series A · $30M · 2025-03
$30M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Corti
Uses AI to assess patients in collaboration with clinicians
Series B · $60M · 2023-09
$60M - Iomed
NLP-based data extraction from medical records, clinical trials and patient surveys
Series A · $11M · 2023-09
$11M - CiaoDott
Vertical AI voice platform for healthcare, supporting clinical communication and decision support for physicians and healthcare institutions
Pre-Seed · $2M · 2026-03
$2M
Other / unspecified
BusinessLatest roundTotal raisedDate- Heidi Health
AI ambient documentation and clinical agent for clinicians (AI Care Partner)
Series C · $437M · 2026-09 · Valuation $900M
$437MValuation $900M - Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M - Kraionyx AI
High-reliability medical AI agents for physicians and healthcare organizations: clinical decision support, ambient voice-to-clinical-notes, physician case collaboration network
—
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
40 Life Sciences deals in the last 24 months · 26 at a nearby stage · 36 in Silicon Valley
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 12 at a nearby stage · 22 in Silicon Valley
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 10 at a nearby stage · 20 in Silicon Valley
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 6 at a nearby stage · 15 in Silicon Valley
Request intro →Lightspeed
17 Life Sciences deals in the last 24 months · 11 at a nearby stage · 15 in Silicon Valley
Request intro →8VC
15 Life Sciences deals in the last 24 months · 9 at a nearby stage · 15 in Silicon Valley
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.